PatientPartner Raises $7M to Revolutionize Patient Engagement

SAN DIEGO, Sept. 4, 2024 /PRNewswire/ -- PatientPartner, a health-tech startup founded by Forbes Under 30 honorees George Kramb and Patrick Frank, raised $7M in Seed Round funding led by LionBird & FCA Venture Partners. The round was comprised of $3.5M in new money and $3.5M of convertible debt from Alethea Capital and other strategic investors.

This new capital will further expand their platform and get closer to their mission of creating a world where patients are informed and supported with each diagnosis, and feel empowered to take the next step in their healthcare journey.

Strategic Investment to Drive Innovation in Pharma Partnerships

Over the past several years PatientPartner has used its unique patient mentoring platform to transform the patient experience and improve outcomes for their pharmaceutical clients. With the growing recognition that patients need more personalized experiences, the pharmaceutical sector has been turning to innovative technologies, like PatientPartner, to address these needs.

Today, the platform has over 40,000 users and more than 500 mentors across a wide array of disease states and treatment types.

Current State Of Patient Engagement & Direct To Patient Marketing

One of the largest emerging trends throughout the healthcare, pharmaceutical, and medical device industries has been the recent investments into their direct to patient initiatives such as Eli Lilly's "LillyDirect" & Pfizer's "PfizerForAll" platforms.

"These efforts are driving progress in bridging the gap between companies' products and the patients who need them. This reflects a strong commitment to improving the patient relationship, which is one of the many factors that has led to our continued growth as a solution in the industry."

 - Says George Kramb, Co-Founder & CEO.

Why PatientPartner Is A Leader In Patient Engagement

Unlike the current industry standards, PatientPartner's platform offers an unprecedented ability to connect patients with mentors in real-time, resulting in patients being proactive on their health.

This unique capability has led to a new industry benchmark of achieving over a 71% success rate in prompting patients to take the next step in their healthcare journey.

"The next chapter of PatientPartner will be focused on expanding its platform, enhancing patient engagement, and personalizing healthcare journeys to improve data-driven outcomes."

 - Says Patrick Frank, Co-Founder & COO

Through its proprietary patient-sentiment reporting, the platform offers deeper insights and more relatable mentor connections which has a positive impact on patient decision-making.

Quotes from Key Stakeholders

"LionBird is excited to support PatientPartner as they revolutionize patient engagement and adherence in the pharmaceutical industry. Their innovative approach to patient mentoring aligns with our vision of backing startups that have the potential to significantly improve healthcare outcomes," said Ed Michael - Partner at LionBird.

About PatientPartner

PatientPartner is a leading health-tech startup focused on improving patient engagement and adherence through its patient mentorship platform. The company partners with pharmaceutical manufacturers, medical device companies, clinical research organizations (CROs), along with other healthcare organizations to deliver scalable technology-driven solutions to provide a personalized experience for every patient.

About FCA Venture Partners

FCA Venture Partners is a venture capital firm investing in early-stage healthcare technology and technology-enabled healthcare services companies that improve patient care, reduce costs, or increase efficiency. FCA manages over $225 million and invests across the Series Seed to Series B stages. FCA brings portfolio companies valuable healthcare insights, connections, and board-level experience to accelerate growth and build disruptive and sustainable businesses. Based in Nashville, the epicenter of healthcare innovation, and Charlotte, the FCA team has a decades-long track record including more than 60 investments in the rapidly changing healthcare industry.